Desmidorchis awdeliana
Desmidorchis awdeliana · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Desmidorchis awdeliana is a botanical species that has gained scientific interest due to its potential pharmacological properties. Research focusing on its crude ethanolic extract and dichloromethane (DCM) fraction has revealed significant bioactive components. Specifically, the presence of flavone glycoside within these preparations plays a crucial role in its chemical profile. These compounds exhibit noteworthy anticholinesterase activities, suggesting a mechanism for neurological modulation. Consequently, these findings highlight the plant's potential application in managing conditions associated with ache and related physiological discomfort.
- Synonyms
- Boucerosia Awdeliana · Ceropegia Awdeliana · 2 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Desmidorchis awdeliana is a plant species known to be associated with several different botanical names within scientific literature. Due to various taxonomic reclassifications, it is frequently identified by the synonym Boucerosia awdeliana. Researchers have also documented the plant under the name Caralluma awdeliana in different contexts. Furthermore, the species is linked to the synonyms Ceropegia awdeliana and Crenulluma awdeliana. Understanding these various nomenclatural relationships is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Desmidorchis awdeliana is a unique botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It is further organized into the order Gentianales, showcasing its specific evolutionary lineage. The plant is a member of the Apocynaceae family, a group known for diverse morphological traits. Finally, it is defined by its placement within the specific genus Desmidorchis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Desmidorchis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Desmidorchis awdeliana is a specialized plant species found within the Asia-Temperate region. Its natural habitat is primarily concentrated across the rugged landscapes of the Arabian Peninsula. Specifically, this orchid can be identified growing in the unique environments of Oman. It also maintains a documented presence within the borders of Yemen. These distinct geographic distributions highlight the plant's specific ecological niche in the Middle East.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Desmidorchis awdeliana, also known as Caralluma awdeliana, has demonstrated notable anticholinesterase activity through recent phytochemical investigations. Researchers utilized a bio-guided isolation approach on the plant's dichloromethane fraction to identify several bioactive constituents, including pregnane glycosides and a flavone glycoside. While the various extracts exhibited strong anti-inflammatory properties, they also showed moderate inhibitory effects against enzymes such as AChE and BChE. Specifically, the compound awdelioside B was identified as having moderate activity against BChE, distinguishing it from other isolated compounds that showed only weak effects. These findings highlight the medicinal potential of the species in targeting enzymatic pathways related to neurological and inflammatory responses.
Compounds
Desmidorchis awdeliana, a medicinal plant native to Yemen, has been identified as a significant source of bioactive chemical compounds. Through a bio-guided isolation approach using dichloromethane fractions, researchers successfully isolated several key constituents from the plant. Notably, the study confirmed that Desmidorchis awdeliana contains flavone glycoside, specifically identified as luteolin 4-O-neohesperidoside. These isolated compounds were further tested for their potential anticholinesterase and anti-inflammatory properties. The findings highlight the plant's therapeutic potential, particularly through its ability to inhibit various enzyme pathways.
Conditions
Desmidorchis awdeliana exhibits significant inhibitory activity against several key enzymes, including 5-LOX, COX-1, and COX-2. The plant's dichloromethane fraction demonstrates potent anti-inflammatory properties by treating these specific cyclooxygenase and lipoxygenase enzymes. Additionally, the plant shows the ability to treat AChE with moderate inhibitory activity. It also provides a therapeutic effect against BChE, particularly through the isolated compound awdelioside B. These combined enzymatic relationships highlight the medicinal potential of the plant in addressing inflammatory and anticholinesterase targets.
Preparations
Desmidorchis awdeliana is prepared as a crude ethanolic extract to facilitate the study of its medicinal properties. From this initial crude ethanolic extract, the plant is further prepared as a dichloromethane (DCM) fraction. This specific DCM fraction serves as the source for isolating various bioactive compounds, including four pregnane glycosides and a flavone glycoside. The preparation of the DCM fraction is essential for demonstrating high inhibitory activity against enzymes such as COX-1, COX-2, and 5-LOX. Ultimately, these distinct preparation methods allow for the identification of potent constituents like awdelioside B.